The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by GTS Securities LLC

GTS Securities LLC grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 484.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,929 shares of the medical device company's stock after acquiring an additional 13,203 shares during the quarter. GTS Securities LLC's holdings in Cooper Companies were worth $1,464,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Byrne Asset Management LLC bought a new position in Cooper Companies during the 4th quarter worth $33,000. OFI Invest Asset Management bought a new stake in shares of Cooper Companies during the 4th quarter valued at about $34,000. New Age Alpha Advisors LLC bought a new stake in shares of Cooper Companies during the fourth quarter valued at approximately $38,000. Covestor Ltd raised its holdings in shares of Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after acquiring an additional 120 shares during the last quarter. Finally, Atala Financial Inc purchased a new position in Cooper Companies during the 4th quarter worth $51,000. 24.39% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Piper Sandler reaffirmed an "overweight" rating and issued a $115.00 price target (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Stifel Nicolaus reduced their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. BNP Paribas upgraded Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Citigroup dropped their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Finally, Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research note on Thursday, May 22nd. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, Cooper Companies presently has an average rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Price Performance

COO stock traded up $1.76 during midday trading on Tuesday, hitting $80.59. The company's stock had a trading volume of 2,684,416 shares, compared to its average volume of 1,498,312. The Cooper Companies, Inc. has a 12 month low of $69.81 and a 12 month high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $16.12 billion, a price-to-earnings ratio of 41.33, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. The company has a 50 day moving average of $80.23 and a two-hundred day moving average of $88.97.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting analysts' consensus estimates of $0.92. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.